A Comparison of Intensive Sequential Chemotherapy Using Doxorubicin Plus Paclitaxel Plus Cyclophosphamide With High Dose Chemotherapy and Autologous Hematopoietic Progenitor Cell Support for Primary Breast Cancer in Women With 4-9 Involved Axillary Lymph Nodes.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics; Carboplatin; Carmustine; Cisplatin; Cyclophosphamide; Doxorubicin; Filgrastim; Paclitaxel; Thiotepa
- Indications Breast cancer
- Focus Therapeutic Use
- 24 Jan 2013 Biomarkers information updated
- 02 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 01 May 2007 Final results published in JCO.